Locations:
SearchAdvertisement
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Can T-cell immunophenotyping help inform treatment decisions?
Chronic headache sufferers may benefit from adjuvant drugs, devices and procedures
Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Scoping review implicates temperature extremes, air pollutants, expanding infectious disease risk
Initial pilot study findings suggest a potential reduced need for cerebrospinal fluid testing
Intracranial injection of supercharged immune cells proceeds to phase 2 testing
Multidisciplinary efforts to refine cerebral hemodynamic goals in a high-risk population
A comprehensive, measured approach is key to long-term management
Medication-focused intervention key to management success in a challenging population
Advertisement
Advertisement